Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Doughty St
Roper Medical Office Building
Charleston, SC 29403
Education & Training
- Topiwala National Medical CollegeClass of 2005
- Medical University of South CarolinaResidency, Child Neurology
- Medical University of South CarolinaFellowship, Epilepsy
Certifications & Licensure
- NY State Medical License 2005 - 2026
- TX State Medical License 2023 - 2026
- UT State Medical License 2023 - 2026
- AZ State Medical License 2023 - 2025
- CO State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- IA State Medical License 2023 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
- Join now to see all
Publications & Presentations
PubMed
- 78 citationsDeep learning applied to whole-brain connectome to determine seizure control after epilepsy surgery.Ezequiel Gleichgerrcht, Brent C. Munsell, Sonal Bhatia, William A. Vandergrift, Chris Rorden
Epilepsia. 2018-09-01 - 5 citationsHealth Disparities in Pediatric Epilepsy: Methods and Lessons Learned.Janelle Wagner, Sonal Bhatia, B Oyinkan Marquis, Imelda Vetter, Christopher W Beatty
Journal of Clinical Psychology in Medical Settings. 2023-06-01 - 1 citationsFARS2 (Phenylalanyl-tRNA Synthetase 2) Deficiency: A Novel Mutation Associated with EEG Phenotype of Epilepsy of Infancy with Migrating Focal Seizures (EIMFS).Carlos Mario Guerrero, Sonal Bhatia
Journal of Pediatric Neurosciences. 2021-10-11
Press Mentions
- Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual MeetingNovember 3rd, 2023
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BApril 30th, 2024
- FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B PatientsApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: